跳至主要内容
临床试验/NCT05378295
NCT05378295已完成不适用

Personalized Microbial Substrates to Prevent Type 2 Diabetes

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2021年11月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
Peripheral insulin sensitivity

研究概览

简要总结

In this project the investigators intend to study the therapeutic potential of a personalized fibre mixture in individuals at high risk of developing T2DM, and aim to address the following key objectives:

  1. To investigate whether a mixture of fermentable fibres, which differ in DP and side chains, will stimulate a broad range of SCFA-producing bacterial genera, resulting in enhanced chronic SCFA production throughout the whole colon with a large variation between individuals;
  2. To unravel whether providing personalized fibre mixtures, selected based on the individuals' initial microbiota and capacity for SCFA production is crucial to successfully improve host insulin sensitivity and metabolic health

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Overweight/obese insulin resistant/prediabetic participants (age 30-70 y, BMI ≥ 28 kg/m2 < 40 kg/m2)

排除标准

  • •Type 2 diabetes mellitus (defined as fasting plasma glucose ≥ 7.0 mmol/L and 2h glucose ≥ 11.1 mmol/L)
  • •Gastroenterological diseases or abdominal surgery;
  • •Cardiovascular diseases, cancer, liver or kidney malfunction, disease with a life expectancy shorter than 5 years;
  • •Abuse of products; alcohol and drugs, excessive nicotine use defined as >20 cigarettes per day;
  • •Plans to lose weight or following of a hypocaloric diet;
  • •Regular supplementation of pre- or probiotic products, use of pre- or probiotics 3 months prior to the start of the study;
  • •Intensive exercise training more than three hours a week;
  • •Use of any medication that influences glucose or fat metabolism and inflammation (i.e. NSAIDs);
  • •Regular use of laxation products;
  • •Use of antibiotics in the last three months (antibiotics use can alter substantially the gut microbiota composition).
  • •Follow a vegetarian diet.

研究组 & 干预措施

isocaloric fermentable oligosaccaride

Active Comparator

isocaloric fermentable oligosaccaride

干预措施: Fermentable oligosaccharide (Dietary Supplement)

Personalized fiber mixture

Experimental

12 g for 2 weeks, followed by 24 g for 10 weeks

干预措施: Personalized fiber mixture (Dietary Supplement)

结局指标

主要结局

Peripheral insulin sensitivity

时间窗: Before and 12 week after the start of the intervention

The change of peripheral insulin sensitivity (m-value) as assessed by a hyperinsulinaemic-euglycemic clamp

次要结局

  • Substrate oxidation (indirect calorimetry)(Before and 12 week after the start of the intervention)
  • circulating SCFA(Before and 12 week after the start of the intervention)
  • Circulating hormones such as insulin(Before and 12 week after the start of the intervention)
  • fat mass(Before and 12 week after the start of the intervention)
  • Energy expenditure (indirect calorimetry)(Before and 12 week after the start of the intervention)
  • Circulating metabolites such as glucose(Before and 12 week after the start of the intervention)
  • body weight(Before and 12 week after the start of the intervention)
  • Faecal SCFA(Before and 12 week after the start of the intervention)
  • Faecal microbiota composition and in vitro microbial activity testing(Before and 12 week after the start of the intervention)
  • body fat percentage(Before and 12 week after the start of the intervention)
  • lean mass(Before and 12 week after the start of the intervention)
  • visceral fat(Before and 12 week after the start of the intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验